Regina Barber

Beth Donovan is our senior director and Colin Campbell is our senior vice president of podcasting strategy. I'm Regina Barber. Thank you for listening to Shortwave from NPR.

Beth Donovan is our senior director and Colin Campbell is our senior vice president of podcasting strategy. I'm Regina Barber. Thank you for listening to Shortwave from NPR.

You're listening to Shortwave from NPR. Hey, short wavers, Regina Barber here, and we're back with the final episode in our series on the science behind psychedelics and related drugs. I'm here with producer Rachel Carlson, who reported out this whole series. Hey, Rachel.

You're listening to Shortwave from NPR. Hey, short wavers, Regina Barber here, and we're back with the final episode in our series on the science behind psychedelics and related drugs. I'm here with producer Rachel Carlson, who reported out this whole series. Hey, Rachel.

You're listening to Shortwave from NPR. Hey, short wavers, Regina Barber here, and we're back with the final episode in our series on the science behind psychedelics and related drugs. I'm here with producer Rachel Carlson, who reported out this whole series. Hey, Rachel.

So is taking the trip out of these drugs new? Like, I feel like I haven't really heard about this before.

So is taking the trip out of these drugs new? Like, I feel like I haven't really heard about this before.

So is taking the trip out of these drugs new? Like, I feel like I haven't really heard about this before.

So today on the show, to trip or not to trip?

So today on the show, to trip or not to trip?

So today on the show, to trip or not to trip?

And I'm Regina Barber. You're listening to Shortwave, the science podcast from NPR.

And I'm Regina Barber. You're listening to Shortwave, the science podcast from NPR.

And I'm Regina Barber. You're listening to Shortwave, the science podcast from NPR.

Okay, Rachel, today we're talking about companies developing new psychedelics, but psychedelics have been used for millennia. So, like, where did this idea come from?

Okay, Rachel, today we're talking about companies developing new psychedelics, but psychedelics have been used for millennia. So, like, where did this idea come from?

Okay, Rachel, today we're talking about companies developing new psychedelics, but psychedelics have been used for millennia. So, like, where did this idea come from?

Oh, OK. So if you increase the number of leaves, the neurons can like communicate with each other better.

Oh, OK. So if you increase the number of leaves, the neurons can like communicate with each other better.

Oh, OK. So if you increase the number of leaves, the neurons can like communicate with each other better.